Form 10-Q McGraw Hill, Inc. For: Sep 30 Nov 5, 2026 07:15AM ... (continue reading...)
Form 8-K Aclaris Therapeutics, For: Nov 05 Nov 5, 2026 07:15AM 0001557746false00015577462026-11-052026-11-05

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

​

​

FORM 8-K

​

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

​

Date of Report (Date of earliest event reported): November 5, 2026

​

​

Aclaris Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

​

​

​

​

​

​

Delaware

​

001-37581

​

46-0571712

(State or other jurisdiction of incorporation)

​

(Commission File Number)

​

(IRS... (continue reading...)


Form 8-K/A TripAdvisor, Inc. For: Nov 01 Nov 5, 2026 07:15AM true000152652000015265202026-11-012026-11-01

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K/A

(Amendment No. 1)

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 1, 2026

TRIPADVISOR, INC.

(Exact name of Registrant as Specified in Its Charter)

Nevada

001-35362

80-0743202

... (continue reading...)
Form 6-K Kandal M Venture Ltd For: Nov 05 Nov 5, 2026 07:15AM

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2026

 

Commission File Number: 001-42715

 

KANDAL M VENTURE LIMITED 

(Registrant’s Name)

 

Padachi Village, Prek Ho Commune, Takhmao Town, Kandal Province, Kingdom of Cambodia

(Address of Principal Executive Offices)

 

... (continue reading...)


Form 8-K C4 Therapeutics, Inc. For: Nov 05 Nov 5, 2026 07:15AM 0001662579false00016625792026-11-052026-11-05UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549_________________________________________________________________FORM 8-K_________________________________________________________________CURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934Date of Report (Date of earliest event reported): November 5, 2026 _________________________________________________________________C4... (continue reading...)

More SEC Filings

View Older Stories

Nov 5, 2026 07:15AM Form 10-Q CENTRUS ENERGY CORP For: Sep 30
Nov 5, 2026 07:14AM Form 8-K McGraw Hill, Inc. For: Nov 05
Nov 5, 2026 07:14AM Form 10-Q Monte Rosa Therapeutics, For: Sep 30
Nov 5, 2026 07:14AM Form 8-K Akebia Therapeutics, For: Nov 05
Nov 5, 2026 07:14AM Form 10-Q Unity Software Inc. For: Sep 30
Nov 5, 2026 07:13AM Form 10-Q OPEN TEXT CORP For: Sep 30
Nov 5, 2026 07:13AM Form 10-Q Climb Bio, Inc. For: Sep 30
Nov 5, 2026 07:13AM Form 8-K CONOCOPHILLIPS For: Nov 05
Nov 5, 2026 07:13AM Form 8-K APPIAN CORP For: Nov 05
Nov 5, 2026 07:13AM Form 13F-HR True Light Capital Pte. For: Sep 30
Nov 5, 2026 07:13AM Form 10-Q TripAdvisor, Inc. For: Sep 30
Nov 5, 2026 07:13AM Form 8-K Kimbell Royalty Partners For: Nov 05
Nov 5, 2026 07:13AM Form 8-K Xeris Biopharma Holdings For: Nov 05
Nov 5, 2026 07:12AM Form 8-K LCI INDUSTRIES For: Nov 05
Nov 5, 2026 07:12AM Form 10-Q WW INTERNATIONAL, INC. For: Sep 30
Nov 5, 2026 07:12AM Form 10-Q TIC Solutions, Inc. For: Sep 30
Nov 5, 2026 07:12AM Form 8-K OPEN TEXT CORP For: Nov 05
Nov 5, 2026 07:12AM Form 8-K Vistance Networks, Inc. For: Nov 05
Nov 5, 2026 07:11AM Form 8-K Tecnoglass Holdings Inc. For: Nov 05
Nov 5, 2026 07:11AM Form 8-K Evolent Health, Inc. For: Nov 05
Nov 5, 2026 07:11AM Form 8-K Envoy Medical, Inc. For: Nov 05
Nov 5, 2026 07:10AM Form 8-K REGENXBIO Inc. For: Nov 05
Nov 5, 2026 07:10AM Form 8-K TripAdvisor, Inc. For: Nov 03
Nov 5, 2026 07:10AM Form 8-K Climb Bio, Inc. For: Nov 05
Nov 5, 2026 07:10AM Form 10-Q Commerce.com, Inc. For: Sep 30
Nov 5, 2026 07:10AM Form 8-K Zenas BioPharma, Inc. For: Nov 05
Nov 5, 2026 07:09AM Form 8-K Certara, Inc. For: Nov 05
Nov 5, 2026 07:09AM Form 8-K Cooper-Standard Holdings For: Nov 04
Nov 5, 2026 07:09AM Form 10-Q Entrada Therapeutics, For: Sep 30
Nov 5, 2026 07:09AM Form 10-Q Korro Bio, Inc. For: Sep 30
Nov 5, 2026 07:08AM Form 8-K Wendy's Co For: Nov 05
Nov 5, 2026 07:08AM Form FWP PRECISION BIOSCIENCES Filed by: PRECISION BIOSCIENCES INC
Nov 5, 2026 07:08AM Form 8-K Six Flags Entertainment For: Nov 05
Nov 5, 2026 07:07AM Form 10-Q Shake Shack Inc. For: Sep 30
Nov 5, 2026 07:07AM Form 8-K 1stdibs.com, Inc. For: Nov 02
Nov 5, 2026 07:07AM Form 10-Q FATE THERAPEUTICS INC For: Sep 30
Nov 5, 2026 07:07AM Form 10-Q Shutterstock, Inc. For: Sep 30
Nov 5, 2026 07:06AM Form 13F-HR Endure Capital Managemen For: Sep 30
Nov 5, 2026 07:06AM Form 8-K GENESIS ENERGY LP For: Nov 05
Nov 5, 2026 07:06AM Form 10-Q Real REMAX Group Inc. For: Sep 30
Nov 5, 2026 07:06AM Form 8-K ACACIA RESEARCH CORP For: Nov 05
Nov 5, 2026 07:06AM Form 8-K TripAdvisor, Inc. For: Nov 05
Nov 5, 2026 07:06AM Form 13F-HR HS Management Partners, For: Sep 30
Nov 5, 2026 07:06AM Form 8-K Latigo Biotherapeutics, For: Nov 03
Nov 5, 2026 07:06AM Form 8-K DTE ENERGY CO For: Nov 01
Nov 5, 2026 07:06AM Form 8-K GPGI, Inc. For: Nov 05
Nov 5, 2026 07:06AM Form 8-K CareCloud, Inc. For: Nov 05
Nov 5, 2026 07:06AM Form 8-K Zoetis Inc. For: Nov 05
Nov 5, 2026 07:06AM Form 8-K IRONWOOD PHARMACEUTICALS For: Nov 05
Nov 5, 2026 07:06AM Form 8-K IOVANCE BIOTHERAPEUTICS, For: Nov 05
View Older Stories